| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |